Transcranial magnetic stimulation for treating depression in elderly patients.

abstract：BACKGROUND:Escitalopram is a selective serotonin reuptake inhibitor, widely used in the treatment of affective disorders. The purpose of this study was to examine its safety and tolerability, as mono- versus augmentative therapy, in a group of patients with affective disorders. MATERIALS AND METHODS:The sample consist...

journal_title：Neuropsychiatric disease and treatment

authors： Dell'osso B,Arici C,Dobrea C,Camuri G,Benatti B,Altamura AC

更新日期：2013-01-01 00:00:00

abstract：:The aim of our study was to understand the complex relationship between the major reproductive life events in women with Alzheimer's disease. In a retrospective, case-control study, 275 women with Alzheimer's disease (AD) and 276 control patients from a hospital population were enrolled from July 2007 to December 2010...

journal_title：Neuropsychiatric disease and treatment

authors： Zucchella C,Sinforiani E,Citterio A,Giarracca V,Bono G,Mauri M

更新日期：2012-01-01 00:00:00

abstract：:Orthostatic hypotension (OH) is a common condition, particularly in patients with α-synucleinopathies such as Parkinson's disease, and has a significant impact on activities of daily living and quality of life. Recent data suggest an association with cognitive impairment. Herein, we review the evidence that OH increas...

journal_title：Neuropsychiatric disease and treatment

authors： Robertson AD,Udow SJ,Espay AJ,Merola A,Camicioli R,Lang AE,Masellis M

更新日期：2019-08-02 00:00:00

abstract：:Mycophenolate mofetil (MMF) has been used to treat myasthenia gravis (MG) for over 10 years. MMF's use in the MG population stems from its theoretical mechanism of action and the medical literature that supports its benefit in MG patients. Recently, two large, double-blinded, placebo-controlled, randomized clinical tr...

journal_title：Neuropsychiatric disease and treatment

authors： Heatwole C,Ciafaloni E

更新日期：2008-12-01 00:00:00

abstract：PURPOSE:Infant resting-state networks do not exhibit the same connectivity patterns as those of young children and adults. Current theories of brain development emphasize developmental progression in regional and network specialization. We compared infant and adult functional connectivity, predicting that infants would...

journal_title：Neuropsychiatric disease and treatment

authors： Wylie KP,Rojas DC,Ross RG,Hunter SK,Maharajh K,Cornier MA,Tregellas JR

更新日期：2014-07-21 00:00:00

abstract：:Ischemic stroke is one of the leading causes of brain disease, with high morbidity, disability, and mortality. MicroRNAs (miRNAs) have been identified as vital gene regulators in various types of human diseases. Accumulating evidence has suggested that aberrant expression of miRNAs play critical roles in the pathologi...

journal_title：Neuropsychiatric disease and treatment

authors： Yao S,Tang B,Li G,Fan R,Cao F

更新日期：2016-12-05 00:00:00

abstract：:Transcranial magnetic stimulation is an increasingly popular FDA-approved treatment for resistant depression, migraines, and OCD. Research is also underway for its use in various other psychiatric and medical disorders. Although rare, seizures are a potential adverse event of TMS treatment. In this article, we discuss...

journal_title：Neuropsychiatric disease and treatment

authors： Stultz DJ,Osburn S,Burns T,Pawlowska-Wajswol S,Walton R

更新日期：2020-12-07 00:00:00

abstract：:Caregiving stress and burden are universal phenomena among family caregivers of people with dementia. Family caregivers who adopted adaptive management strategies in dementia care could alleviate their own distress and the progression of neuropsychiatric symptoms in people with dementia. An understanding about the man...

journal_title：Neuropsychiatric disease and treatment

authors： Chien WT

更新日期：2015-07-09 00:00:00

abstract：:Adjunctive use of methylphenidate, a central stimulant, has been considered as a potential therapeutic choice for patients with refractory unipolar, geriatric, or bipolar depression, and depression secondary to medical illness. We present a case of bipolar depression in which the patient responded significantly to aug...

journal_title：Neuropsychiatric disease and treatment

authors： Adida M,Azorin JM

更新日期：2014-04-02 00:00:00

abstract：BACKGROUND:Physical exercise has well-characterized positive effects on depressive symptoms. The underlying biologic mechanisms are, however, far from established. A recently discovered mechanism has linked the enhanced conversion of kynurenine to kynurenic acid (KYNA) to an increased resilience toward stress-induced d...

journal_title：Neuropsychiatric disease and treatment

authors： Millischer V,Erhardt S,Ekblom Ö,Forsell Y,Lavebratt C

更新日期：2017-03-31 00:00:00

abstract：:Isotretinoin, a drug used for moderate to severe acne, has been repeatedly associated with various psychiatric complications, although a definitive causal relationship has not been established to date. This case report describes a 25-year-old male who developed obsessive-compulsive disorder at the age of 23 years foll...

journal_title：Neuropsychiatric disease and treatment

authors： Fornaro M

更新日期：2010-10-29 00:00:00

abstract：:Parkinson's disease (PD) is one of the most frequent neurological diseases. Despite the modern imaging and nuclear techniques which help to diagnose it in a very early stage and lead to a better discrimination of similar diseases, PD has remained a clinical diagnosis. The increasing number of available treatment optio...

journal_title：Neuropsychiatric disease and treatment

authors： Pedrosa DJ,Timmermann L

更新日期：2013-01-01 00:00:00

abstract：:Elevation of plasma inflammatory factors in major depressive disorder (MDD) has been repeatedly observed, but contradictory results have also been reported. Alteration of complement components in MDD may also contribute to the pathophysiology of MDD by participating in inflammation. The recent findings that complement...

journal_title：Neuropsychiatric disease and treatment

authors： Wei J,Liu Y,Zhao L,Yang X,Ni P,Wang Y,Li T,Ma X

更新日期：2017-12-20 00:00:00

abstract：OBJECTIVE OF THE STUDY:To evaluate the value of serum creatine phosphokinase-brain specific (CK-BB) and urinary lactate/creatinine (L/C) ratio as early indicators of brain damage in full-term newborns with hypoxic ischemic encephalopathy (HIE). PATIENTS AND METHODS:A case-control study including 25 full-term new-born ...

journal_title：Neuropsychiatric disease and treatment

authors： Alkholy UM,Abdalmonem N,Zaki A,Ali YF,Mohamed SA,Abdelsalam NI,Hashim MIA,Sekkien MA,Elsherbiny YM

更新日期：2017-08-08 00:00:00

abstract：OBJECTIVE:To describe antidepressant (AD) use in the treatment of major depressive disorder during a period of economic crisis. PATIENTS AND METHODS:This was a retrospective, observational study using population-based databases. Two periods were considered: 1) 2008-2009, precrisis, and 2) 2012-2013, economic crisis. C...

journal_title：Neuropsychiatric disease and treatment

authors： Sicras-Mainar A,Navarro-Artieda R

更新日期：2015-12-30 00:00:00

abstract：BACKGROUND:We assessed the effect of switching patients with major depressive disorder to milnacipran following an initial selective serotonin reuptake inhibitor treatment failure, and explored potential biomarkers in their blood. METHODS:We conducted a prospective, open-label, 24-week trial. Depression was assessed w...

journal_title：Neuropsychiatric disease and treatment

authors： Hashimoto T,Sakurai D,Oda Y,Hasegawa T,Kanahara N,Sasaki T,Komatsu H,Takahashi J,Oiwa T,Sekine Y,Watanabe H,Iyo M

更新日期：2015-12-10 00:00:00

abstract：:To date, the role of metabotropic glutamate receptor 3 (GRM3) rs274622, rs1468412, rs917071, rs6465084, and rs2299225 polymorphisms in schizophrenia remains controversial. To provide a clearer picture for the effect of the five most studied GRM3 polymorphisms on risk of schizophrenia, this meta-analysis with eligible ...

journal_title：Neuropsychiatric disease and treatment

authors： Yang X,Wang G,Wang Y,Yue X

更新日期：2015-03-25 00:00:00

abstract：:Up to 20% of depressed patients demonstrate treatment resistance to one or more adequate antidepressant trials, resulting in a disproportionately high burden of illness. Ketamine is a non-barbiturate, rapid-acting general anesthetic that has been increasingly studied in treatment resistant depression (TRD), typically ...

journal_title：Neuropsychiatric disease and treatment

authors： Jankauskas V,Necyk C,Chue J,Chue P

更新日期：2018-06-06 00:00:00

abstract：BACKGROUND:Encephalitis with antibodies against N-methyl-D-aspartate receptor (NMDA-R) is classified as an autoimmune disorder with psychotic symptoms, which are frequently dominant. However, it remains unclear how frequently NMDA-R antibodies lead to a condition that mimics psychosis and first-episode schizophrenia. I...

journal_title：Neuropsychiatric disease and treatment

authors： Masopust J,Andrýs C,Bažant J,Vyšata O,Kuca K,Vališ M

更新日期：2015-03-06 00:00:00

abstract：:To determine relationships between the need for dental treatments of institutionalized elderly people and cognitive impairment and the general level of care needed. Two hundred and sixty-eight residents of long-term care facilities in Germany were included in this study. Age, sex, diseases, number of frequently taken ...

journal_title：Neuropsychiatric disease and treatment

authors： Zenthöfer A,Rammelsberg P,Cabrera T,Hassel AJ

更新日期：2014-12-02 00:00:00

abstract：BACKGROUND:Previous studies have demonstrated that long noncoding RNA cancer susceptibility candidate 2 (lncRNA CASC2) is frequently downregulated in several types of tumors and functions as a tumor-suppressive factor. However, the clinical significance and function of CASC2 in human glioma remain largely unknown. The ...

journal_title：Neuropsychiatric disease and treatment

authors： Wang R,Li Y,Zhu G,Tian B,Zeng W,Yang Y,Li Z

更新日期：2017-07-11 00:00:00

abstract：BACKGROUND:Preliminary placebo-controlled evidence paved the ground to the US Food and Drug Administration approval extension of lisdexamfetamine for the treatment of moderate-to-severe binge eating disorder (BED) in adults. OBJECTIVES:To provide a preliminary qualitative and quantitative synthesis of the placebo-cont...

journal_title：Neuropsychiatric disease and treatment

authors： Fornaro M,Solmi M,Perna G,De Berardis D,Veronese N,Orsolini L,Ganança L,Stubbs B

更新日期：2016-07-25 00:00:00

abstract：BACKGROUND:The body dysmorphic disorder is prevalent in general population and in psychiatric, dermatological, and plastic-surgery patients, but there lacks a structure-validated, comprehensive self-report measure of body image concerns, which is established through both exploratory and confirmatory factor analyses. M...

journal_title：Neuropsychiatric disease and treatment

authors： He W,Zheng Q,Ji Y,Shen C,Zhu Q,Wang W

更新日期：2017-05-29 00:00:00

abstract：BACKGROUND:Approximately 30%-60% of adults diagnosed with bipolar disorder (BD) report onset between the ages 15 and 19 years; however, a correct diagnosis is often delayed by several years. Therefore, investigations of the early features of BD are important for adequately understanding the prodromal stages of the illn...

journal_title：Neuropsychiatric disease and treatment

authors： Goetz M,Novak T,Vesela M,Hlavka Z,Brunovsky M,Povazan M,Ptacek R,Sebela A

更新日期：2015-11-04 00:00:00

abstract：:In Diagnostic and Statistical Manual of Mental Disorders, fifth edition, psychogenic non-epileptic seizures (PNES) do not have a unique classification as they can be found within different categories: conversion, dissociative, and somatization disorders. The ICD-10, instead, considers PNES within dissociative disorder...

journal_title：Neuropsychiatric disease and treatment

authors： Beghi M,Negrini PB,Perin C,Peroni F,Magaudda A,Cerri C,Cornaggia CM

更新日期：2015-09-30 00:00:00

abstract：OBJECTIVES:Although bipolar disorder has been understood classically as a cyclic disease with full recovery between mood episodes, in the last decade, evidence has accumulated supporting progressive features. The clinical picture of advanced or end-stage bipolar disorder is heterogeneous with possible deficits in cogni...

journal_title：Neuropsychiatric disease and treatment

authors： Dols A,Krudop W,Möller C,Shulman K,Sajatovic M,Pijnenburg YA

更新日期：2016-09-07 00:00:00

abstract：BACKGROUND:There have not been any reports in Japan clarifying the efficacy and safety of intramuscular (IM) olanzapine and IM levomepromazine in agitated elderly patients with schizophrenia. This study was a comparative investigation of the clinical efficacy and safety of IM olanzapine and IM levomepromazine in agitat...

journal_title：Neuropsychiatric disease and treatment

authors： Suzuki H,Gen K

更新日期：2013-01-01 00:00:00

abstract：BACKGROUND:Oral cholinesterase inhibitors at doses efficacious for the treatment of Alzheimer's disease (AD) are often prematurely discontinued due to gastrointestinal side effects. In controlled clinical trials, transdermal rivastigmine demonstrated less such effects at similar efficacy. The current study aimed to ver...

journal_title：Neuropsychiatric disease and treatment

authors： Seibert J,Tracik F,Articus K,Spittler S

更新日期：2012-01-01 00:00:00

abstract：Purpose:Ginkgo biloba extract (GBE) contains diterpene ginkgolides (DGs), which have been shown to have neuroprotective effects by a number of previous studies. We previously demonstrated part of the action of DG. However, the impact of DG on the prefrontal cortex (PFC) remains unclear. Here, we evaluated the effects o...

journal_title：Neuropsychiatric disease and treatment

authors： Hu Q,Shen P,Bai S,Dong M,Liang Z,Chen Z,Wang W,Wang H,Gui S,Li P,Xie P

更新日期：2018-04-13 00:00:00

abstract：BACKGROUND:Stroke has high mortality and morbidity. Biomarkers are required for to predict stroke outcomes, which could help clinicians to provide rationale approaches for patient management. The dynamic changes in circulating immune cells have been reported in stroke patients and animal models of stroke. AIM:The aim ...

journal_title：Neuropsychiatric disease and treatment

authors： Wang Y,Liu J,Wang X,Liu Z,Li F,Chen F,Geng X,Ji Z,Du H,Hu X

更新日期：2017-10-03 00:00:00